In case you haven’t heard enough about Wednesday’s CRISPR patent ruling, we decided to tally up the winners in another court: the world of scientific prizes.

Turns out, it’s not so easy to discern who’s ahead in prizes awarded for science related to CRISPR. But dollars and shares are two ways to get a sense. Some awards are announced with prize money amounts; some aren’t.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy